# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-020371
Filing Date
2021-04-23
Accepted
2021-04-23 16:45:23
Documents
9
Period of Report
2021-06-11

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | adpt-def14a_20210611.htm | DEF 14A | 1371484
2 | GRAPHIC | gug4wb5muyrt000005.jpg | GRAPHIC | 319411
3 | GRAPHIC | gug4wb5muyrt000001.jpg | GRAPHIC | 74467
4 | GRAPHIC | gug4wb5muyrt000007.jpg | GRAPHIC | 925936
5 | GRAPHIC | gug4wb5muyrt000003.jpg | GRAPHIC | 74467
6 | GRAPHIC | gug4wb5muyrt000006.jpg | GRAPHIC | 10527
7 | GRAPHIC | gug4wb5muyrt000002.jpg | GRAPHIC | 4439
8 | GRAPHIC | gug4wb5muyrt000008.jpg | GRAPHIC | 77426
9 | GRAPHIC | gug4wb5muyrt000004.jpg | GRAPHIC | 10527
| Complete submission text file | 0001564590-21-020371.txt |  | 3435460

Mailing Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102
Business Address 1551 EASTLAKE AVENUE EAST SUITE 200 SEATTLE WA 98102 206-659-0067
Adaptive Biotechnologies Corp (Filer) CIK: 0001478320 (see all company filings)

EIN.: 270907024 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38957 | Film No.: 21850438
SIC: 2836 Biological Products, (No Diagnostic Substances)